CellWell record HH-567062
Carbohydrate antigen 72-4 and tumor-associated glycoprotein 72 - tumor marker: Past, present and future
Rui-Kyi Ng; Vishal G Shelat
2026
In plain language
Current evidence supports CA72-4 as an adjunctive marker, not a screening test, most defensibly for gastric cancer risk and peritoneal disease assessment, according to this narrative review.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-567062
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.